triazoles has been researched along with Drug-Related Side Effects and Adverse Reactions in 75 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 17 (22.67) | 29.6817 |
| 2010's | 54 (72.00) | 24.3611 |
| 2020's | 4 (5.33) | 2.80 |
| Authors | Studies |
|---|---|
| Leong, R; O'Flynn, R; Straus, W; Waskin, H; Zhou, YP | 1 |
| Aram, JA; Cao, G; Cornely, OA; Desai, A; Fayyad, R; Guo, X; Hamed, K; Wu, D; Zhang, J; Zhang, Y | 1 |
| Borman, AM; Fraser, M; Hughes, JM; Johnson, EM; Noel, AR; Oliver, D; Sunderland, J | 1 |
| Almeida, IC; Alonso-Vega, C; Barboza, T; Barreira, F; Bilbe, G; Blum, B; Correia, E; Garcia, W; Gascón, J; Ortiz, L; Parrado, R; Ramirez, JC; Ribeiro, I; Sosa-Estani, S; Strub-Wourgaft, N; Torrico, F; Vaillant, M | 1 |
| Assaf, A; Chaftari, AM; Hachem, R; Jiang, Y; Numan, Y; Raad, II; Shah, P | 1 |
| Alberto Arnaiz, J; Amin, J; Andrade-Villanueva, J; Belloso, W; Clark, A; Clarke, A; Cooper, D; Emery, S; Gatell, J; Gill, J; Harrigan, R; Horban, A; Kaiser, R; Kelleher, A; Losso, M; Madero, JS; Mallon, P; Pett, SL; Porteiro, N; Prazuck, T; Rockstroh, JK; Ruxrungtham, K; Silk, D; Sugiura, W; Tu, E; Wolff, M; Woolley, I | 1 |
| Bertaccini, P; Castagnetti, F; Cavo, M; Faccioli, L; Lewis, RE; Paolucci, M; Primavera, L; Rizzello, I; Spinardi, L; Stanzani, M; Toschi, PG | 1 |
| Aoun, M; Cornely, OA; Geddes, M; Grigg, A; Haider, S; Hammond, SP; Heinz, WJ; Hepler, DA; Kartsonis, NA; Maertens, J; Meyer, RG; Mullane, KM; Ostermann, H; Raad, I; Robertson, MN; Schanz, U; Ullmann, AJ; Van Iersel, MLPS; Waskin, H; Zimmerli, S | 1 |
| Evans, D; Fernandes, P; Pereira, D; Wu, S; Yalkowsky, S | 1 |
| Amat, P; Calabuig, M; Hernández-Boluda, JC; Navarro, D; Pérez-Martínez, A; Solano, C; Tormo, M | 1 |
| Andenmatten, N; Chalon, S; Chang, M; Duke, ER; Duparc, S; Ferguson, S; Fishbaugher, M; Fong, Y; Fritzen, E; Gillespie, K; Hanron, AE; Janes, HE; Jensen, RL; Kappe, SH; Kerr, N; Kublin, JG; Marcsisin, SR; Möhrle, JJ; Murphy, SC; Rinn, L; Rueckle, T; Seilie, AM; Shipman, KJ; Sousa, JC; VonGoedert, T | 1 |
| Almeida, IC; Alonso-Vega, C; Alves, F; Gascon, J; Ortiz, L; Pinazo, MJ; Ribeiro, I; Schijman, A; Strub-Wourgaft, N; Torrico, F | 1 |
| Li, S; Yang, L; Yang, M; Zhao, Z | 1 |
| Cahn, P; DeJesus, E; Hanna, GJ; Hwang, C; Kumar, S; Lai, MT; Lombaard, J; Lupinacci, L; Molina, JM; Nguyen, BY; Rodgers, A; Sax, PE; Sklar, P; Squires, K; Xu, X | 1 |
| Cornely, OA; Croos-Dabrera, R; Giladi, M; Lademacher, C; Lu, Q; Maher, RM; Marty, FM; Mullane, KM; Oren, I; Ostrosky-Zeichner, L; Perfect, JR; Rahav, G; Schmitt-Hoffmann, AH | 2 |
| Andersen, LO; Arendrup, MC; Hare, RK; Irga-Jaworska, N; Jaworski, R; Jensen, HE; Malecka, A; Nielsen, HV; Pomorska, A; Radon-Proskura, J | 1 |
| DiPippo, AJ; Kontoyiannis, DP; Rausch, CR | 1 |
| de Boer, MGJ; van de Peppel, RJ; van der Beek, MT; Visser, LG; Wallinga, J | 1 |
| Bongomin, F; Felton, T; Maguire, N; Moore, CB; Rautemaa-Richardson, R | 1 |
| Athans, V; Brizendine, KD; Hassouna, H | 1 |
| Cardozo, C; Diago, E; Enzenhofer, M; Fortun, J; Frutos, A; Garcia-Vidal, C; Gioia, F; Gudiol, C; José Castón, J; López, J; Machado, M; Martín-Dávila, P; Muñoz, P; Parody, R; Puerta-Alcalde, P; Ramos, A | 1 |
| Angelucci, E; Aquino, S; Di Grazia, C; Dominietto, A; Furfaro, E; Ghiggi, C; Ghiso, A; Mikulska, M; Raiola, AM; Signori, A; Ungaro, R; Viscoli, C | 1 |
| Abe, M; Fujii, M; Fukuzawa, M; Hata, Y; Hattori, N; Iozumi, K; Ito, Y; Kasai, H; Katayama, I; Kato, F; Kato, I; Kiryu, H; Kodama, K; Kusuhara, M; Maruyama, R; Mayama, J; Mochizuki, T; Muramoto, F; Nakasu, I; Nishimoto, S; Nomiyama, T; Oh-I, T; Omi, T; Onoduka, T; Sato, T; Sei, Y; Seishima, M; Shimoyama, H; Shindo, M; Sugiura, K; Takahashi, H; Takeda, O; Takenaka, M; Tomizawa, K; Tsuboi, R; Uesugi, T; Watanabe, S; Yamamoto, O; Yamanaka, K; Yasuda, H | 1 |
| Bedoschi, G; Moy, F; Oktay, K; Turan, V | 1 |
| Ingle, JN | 1 |
| Malloch, L; Rhoton-Vlasak, A | 1 |
| Bonnefoi, H; Coates, AS; Cole, BF; Colleoni, M; Ejlertsen, B; Forbes, JF; Gelber, RD; Giobbie-Hurder, A; Goldhirsch, A; Huober, J; Láng, I; Neven, P; Price, KN; Rabaglio, M; Smith, I; Thürlimann, B; Wardley, A; Wu, J | 1 |
| Botes, M; Burnside, R; Clumeck, N; Cooper, DA; Dejesus, E; Heera, J; Ive, P; Lazzarin, A; Mukwaya, G; Saag, M; van Der Ryst, E; Walmsley, S | 1 |
| Bourdelin, M; Daguindau, E; Deconinck, E; Desbrosses, Y; Dubut, J; Grenouillet, F; Larosa, F; Limat, S; Muret, P | 1 |
| Kim, JH; Williams, K | 1 |
| Marchesini, G; Melchiorri, D; Montilla, S; Pani, L; Sammarco, A; Siviero, PD; Tomino, C; Trotta, MP | 1 |
| Fan, H; Wang, JF; Xue, Y; Zhu, XB | 1 |
| Cabanillas Stanchi, KM; Döring, M; Ebinger, M; Eikemeier, M; Handgretinger, R; Hartmann, U; Müller, I; Schulz, A; Schwarze, CP | 1 |
| Fan, S; Li, T; Liang, Y; Liu, X; Xu, H; Zhu, Y | 1 |
| Kauffman, CA; Miceli, MH | 1 |
| Anderson, MS; Butterton, JR; De Lepeleire, I; Gilmartin, J; Guo, Y; Liu, R; Robberechts, M; Schürmann, D; Sobotha, C; Wagner, F; Wagner, JA; Yee, KL | 1 |
| Connell, BJ; Hoepelman, AI; Nijhuis, M; Symons, J; van Ham, P; van Lelyveld, SF; Wensing, AM | 1 |
| El Rassi, F; Saliba, AN; Taher, AT | 1 |
| Isin, EM; Mettetal, JT; Ogese, MO; Thompson, RA; Williams, DP | 1 |
| Adlis, SA; Kirstein, MN; Lerner, RE; Liang, S; Richter, SA; Robien, K; Shapiro, AC | 1 |
| Ananda-Rajah, MR; Bajel, A; Chen, SC; Grigg, A; Haywood, P; Jeong, W; Kong, DC; Lindsay, J; Peleg, AY; Ritchie, D; Seymour, JF; Shanmuganathan, N; Slavin, MA; Urbancic, K | 1 |
| Belardinelli, L; Clancy, CE; El-Bizri, N; Giles, WR; Rajamani, S; Romero, L; Yang, PC | 1 |
| Blaeschke, F; Cabanillas Stanchi, KM; Döring, M; Ebinger, M; Eikemeier, M; Feucht, J; Feuchtinger, T; Handgretinger, R; Heinz, WJ; Klinker, H; Schwarze, CP | 1 |
| Hussar, DA | 3 |
| Brewer, C; Gonzalez, I; Nick, H; Otto-Duessel, M; Wood, JC | 1 |
| Kao, DP | 1 |
| Cappellini, MD; Porter, JB; Taher, AT; Vichinsky, EP | 1 |
| Al Jefri, A; Al Zir, K; Daar, S; El-Beshlawy, A; Elalfy, MS; Habr, D; Hmissi, A; Kriemler-Krahn, U; Taher, A | 1 |
| Amrein, C; Benammar, M; Berge, M; Billaud, EM; Boussaud, V; Chevalier, P; Guillemain, R; Lefeuvre, S | 1 |
| Shah, RR | 1 |
| Allenet, B; Auzéric, M; Bedouch, P; Bellemère, J; Charpiat, B; Conort, O; Juste, M; Rose, FX; Roubille, R | 1 |
| Christen, S; Egger, SS; Gratwohl, A; Haschke, M; Krähenbühl, S; Leu, C; Meier, S | 1 |
| Conry, J; Krauss, G; LoPresti, A; Mann, A; Narurkar, M; Wheless, JW | 1 |
| Azria, D; Belkacemi, Y; Coelho, M; Crompton, NE; Fenoglietto, P; Gourgou, S; Gutowski, M; Lemanski, C; Moscardo, CL; Ozsahin, M; Romieu, G; Rosenstein, B; Zaman, K | 1 |
| Kontoghiorghes, GJ | 1 |
| George, J; Reboli, AC | 1 |
| Aoun, M; Gadisseur, A; Jacobs, F; Selleslag, D; Sonet, A | 1 |
| Berard, F; Martin, O; Nicolas, JF; Rozieres, A; Said, BB | 1 |
| Gray, C; Labois, A; Lepretre, S | 1 |
| de Heredia, CD; Figueras, C; Frick, MA; Lanaspa, M; Martín-Nalda, A; Pou, L; Roselló, E; Soler-Palacín, P | 1 |
| Auzinger, G; Borges Sá, M; Dimopoulos, G; Grigoras, I; Kantecki, M; Marček, T; Meersseman, W; Menichetti, F; Miller, PJ; Montravers, P; Pachl, J; Paiva, JA; Ruhnke, M; Sganga, G | 1 |
| Blyth, CC; Cole, C; Gottardo, NG; Hansford, JR | 1 |
| Ieda, M; Kobayashi, D; Ohshima, S; Yamamoto, M | 1 |
| Bergeron, A; Bergot, E; Bourdin, A; Cadranel, J; Cottin, V; Germaud, P; Godet, C; Hennequin, C; Jeanfaivre, T; Philippe, B; Pineau, M | 1 |
| Buclin, T; Genton, A | 1 |
| Sasich, LD; Sukkari, SR | 1 |
| Bigal, ME; Krymchantowski, AV | 1 |
| Odds, FC | 1 |
| Gilbert, M; Laustsen, G; Wimett, L | 1 |
| Goldberg, SL | 1 |
| Carpenter, R | 1 |
| Abdel-Megeed, AM; Abdel-Rahman, HM; Alkaramany, GE; El-Gendy, MA | 1 |
15 review(s) available for triazoles and Drug-Related Side Effects and Adverse Reactions
| Article | Year |
|---|---|
Plain language summary: use of isavuconazole in Chinese patients with an invasive fungal disease.
Topics: Antifungal Agents; Aspergillosis; Drug-Related Side Effects and Adverse Reactions; Healthy Volunteers; Humans; Invasive Fungal Infections; Mycoses; Nitriles; Pyridines; Triazoles; Voriconazole | 2022 |
Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukaemia.
Topics: Amphotericin B; Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Endophthalmitis; Female; Fungemia; Fusariosis; Fusarium; Humans; Immunocompromised Host; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2018 |
Isavuconazole in a Successful Combination Treatment of Disseminated Mucormycosis in a Child with Acute Lymphoblastic Leukaemia and Generalized Haemochromatosis: A Case Report and Review of the Literature.
Topics: Amphotericin B; Antifungal Agents; Caspofungin; Child; Cunninghamella; Debridement; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Hemochromatosis; Humans; Invasive Fungal Infections; Mucormycosis; Nitriles; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyridines; Treatment Outcome; Triazoles | 2019 |
Postmenopausal women with hormone receptor-positive breast cancer: balancing benefit and toxicity from aromatase inhibitors.
Topics: Aged; Aged, 80 and over; Aromatase Inhibitors; Breast Neoplasms; Cardiovascular Diseases; Chemotherapy, Adjuvant; Drug-Related Side Effects and Adverse Reactions; Estrogen Antagonists; Female; Follow-Up Studies; Fractures, Bone; Humans; Letrozole; Mastectomy, Segmental; Middle Aged; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Randomized Controlled Trials as Topic; Risk Assessment; Survival Analysis; Tamoxifen; Treatment Outcome; Triazoles | 2013 |
Efficacy and safety of echinocandins versus triazoles for the prophylaxis and treatment of fungal infections: a meta-analysis of RCTs.
Topics: Antifungal Agents; Chemoprevention; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Humans; Mycoses; Randomized Controlled Trials as Topic; Survival Analysis; Treatment Outcome; Triazoles | 2015 |
Isavuconazole: A New Broad-Spectrum Triazole Antifungal Agent.
Topics: Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Humans; Invasive Pulmonary Aspergillosis; Mucormycosis; Nitriles; Pyridines; Randomized Controlled Trials as Topic; Treatment Outcome; Triazoles | 2015 |
Clinical monitoring and management of complications related to chelation therapy in patients with β-thalassemia.
Topics: Benzoates; beta-Thalassemia; Chelation Therapy; Deferasirox; Deferiprone; Deferoxamine; Disease Management; Drug-Related Side Effects and Adverse Reactions; Female; Ferritins; Humans; Iron; Iron Chelating Agents; Iron Overload; Liver; Magnetic Resonance Imaging; Male; Myocardium; Pregnancy; Pyridones; Triazoles | 2016 |
Reactive Metabolites: Current and Emerging Risk and Hazard Assessments.
Topics: Acetaminophen; Analgesics, Non-Narcotic; Animals; Antidepressive Agents, Second-Generation; Chemical and Drug Induced Liver Injury; Drug Hypersensitivity; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Pharmaceutical Preparations; Piperazines; Risk Assessment; Triazoles | 2016 |
Drug-induced QT interval shortening: potential harbinger of proarrhythmia and regulatory perspectives.
Topics: Animals; Anticonvulsants; Drug Approval; Drug Design; Drug-Related Side Effects and Adverse Reactions; Humans; KATP Channels; Legislation, Drug; Long QT Syndrome; Triazoles | 2010 |
Safety and tolerability of rufinamide in children with epilepsy: a pooled analysis of 7 clinical studies.
Topics: Adolescent; Age Factors; Anticonvulsants; Child; Child, Preschool; Clinical Trials as Topic; Disorders of Excessive Somnolence; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Epilepsy; Female; Headache; Humans; Male; Treatment Outcome; Triazoles; Vomiting | 2009 |
Anidulafungin: when and how? The clinician's view.
Topics: Anidulafungin; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Drug Resistance, Fungal; Drug Synergism; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Humans; Itraconazole; Microbial Sensitivity Tests; Pyrimidines; Triazoles; Voriconazole | 2012 |
Rizatriptan in migraine.
Topics: Dose-Response Relationship, Drug; Drug Tolerance; Drug-Related Side Effects and Adverse Reactions; Expert Testimony; Humans; Meta-Analysis as Topic; Migraine Disorders; Serotonin Receptor Agonists; Triazoles; Tryptamines | 2005 |
Drug evaluation: BAL-8557--a novel broad-spectrum triazole antifungal.
Topics: Animals; Antifungal Agents; Aspergillosis; Aspergillus; Candida; Candidiasis; Clinical Trials, Phase II as Topic; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Humans; Nitriles; Pyridines; Triazoles | 2006 |
Novel treatment options for transfusional iron overload in patients with myelodysplastic syndromes.
Topics: Benzoates; Deferasirox; Deferiprone; Drug-Related Side Effects and Adverse Reactions; Humans; Iron Chelating Agents; Iron Overload; Myelodysplastic Syndromes; Pyridones; Survival Rate; Transfusion Reaction; Treatment Outcome; Triazoles | 2007 |
Choosing early adjuvant therapy for postmenopausal women with hormone-sensitive breast cancer: aromatase inhibitors versus tamoxifen.
Topics: Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Breast Neoplasms; Chemotherapy, Adjuvant; Disease-Free Survival; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Letrozole; Neoplasms, Hormone-Dependent; Nitriles; Postmenopause; Tamoxifen; Triazoles | 2008 |
17 trial(s) available for triazoles and Drug-Related Side Effects and Adverse Reactions
| Article | Year |
|---|---|
New regimens of benznidazole monotherapy and in combination with fosravuconazole for treatment of Chagas disease (BENDITA): a phase 2, double-blind, randomised trial.
Topics: Adult; Bolivia; Chagas Disease; Double-Blind Method; Drug Administration Schedule; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Nitroimidazoles; Parasite Load; Treatment Outcome; Triazoles; Young Adult | 2021 |
Week 96 results of the randomized, multicentre Maraviroc Switch (MARCH) study.
Topics: Adult; Antiretroviral Therapy, Highly Active; CCR5 Receptor Antagonists; Cyclohexanes; Drug Substitution; Drug-Related Side Effects and Adverse Reactions; HIV Infections; HIV Protease Inhibitors; HIV-1; Humans; Maraviroc; Reverse Transcriptase Inhibitors; RNA, Viral; Treatment Outcome; Triazoles; Viral Load | 2018 |
Pharmacokinetics and safety results from the Phase 3 randomized, open-label, study of intravenous posaconazole in patients at risk of invasive fungal disease.
Topics: Administration, Intravenous; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemoprevention; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Immunocompromised Host; Invasive Fungal Infections; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Triazoles; Young Adult | 2017 |
A Randomized Trial Evaluating the Prophylactic Activity of DSM265 Against Preerythrocytic Plasmodium falciparum Infection During Controlled Human Malarial Infection by Mosquito Bites and Direct Venous Inoculation.
Topics: Adolescent; Adult; Animals; Antimalarials; Chemoprevention; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Malaria, Falciparum; Male; Middle Aged; Parasitemia; Placebos; Plasmodium falciparum; Pyrimidines; Real-Time Polymerase Chain Reaction; Treatment Outcome; Triazoles; Young Adult | 2018 |
Treatment of adult chronic indeterminate Chagas disease with benznidazole and three E1224 dosing regimens: a proof-of-concept, randomised, placebo-controlled trial.
Topics: Administration, Oral; Adolescent; Adult; Bolivia; Chagas Disease; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Incidence; Male; Middle Aged; Nitroimidazoles; Parasite Load; Placebos; Polymerase Chain Reaction; Prospective Studies; Thiazoles; Treatment Outcome; Triazoles; Trypanocidal Agents; Trypanosoma cruzi; Young Adult | 2018 |
Doravirine versus ritonavir-boosted darunavir in antiretroviral-naive adults with HIV-1 (DRIVE-FORWARD): 48-week results of a randomised, double-blind, phase 3, non-inferiority trial.
Topics: Adult; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Darunavir; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; HIV-1; Humans; Male; Middle Aged; Pyridones; Ritonavir; RNA, Viral; Treatment Outcome; Triazoles; Viral Load | 2018 |
Isavuconazole for treatment of invasive fungal diseases caused by more than one fungal species.
Topics: Administration, Intravenous; Adult; Aged; Antifungal Agents; Aspergillosis; Aspergillus; Coinfection; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Mucorales; Mucormycosis; Nitriles; Pyridines; Treatment Outcome; Triazoles | 2018 |
Isavuconazole for treatment of rare invasive fungal diseases.
Topics: Administration, Intravenous; Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Survival Analysis; Treatment Outcome; Triazoles; Young Adult | 2018 |
Efficacy of long-term treatment with efinaconazole 10% solution in patients with onychomycosis, including severe cases: A multicenter, single-arm study.
Topics: Administration, Topical; Aged; Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Female; Foot Dermatoses; Humans; Incidence; Long-Term Care; Male; Middle Aged; Onychomycosis; Quality of Life; Severity of Illness Index; Time Factors; Treatment Outcome; Triazoles | 2019 |
Efficacy and safety of maraviroc vs. efavirenz in treatment-naive patients with HIV-1: 5-year findings.
Topics: Adolescent; Adult; Aged; Alkynes; Anti-HIV Agents; Antiretroviral Therapy, Highly Active; Benzoxazines; CD4 Lymphocyte Count; Cyclohexanes; Cyclopropanes; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; HIV-1; Humans; Male; Maraviroc; Middle Aged; Treatment Outcome; Triazoles; Viral Load; Young Adult | 2014 |
A randomized clinical trial of the efficacy and safety of terconazole vaginal suppository versus oral fluconazole for treating severe vulvovaginal candidiasis.
Topics: Administration, Oral; Adolescent; Adult; Antifungal Agents; Candidiasis, Vulvovaginal; Case-Control Studies; China; Drug-Related Side Effects and Adverse Reactions; Female; Fluconazole; Humans; Middle Aged; Prospective Studies; Suppositories; Treatment Outcome; Triazoles; Young Adult | 2015 |
A randomized, double-blind, placebo-controlled, short-term monotherapy study of doravirine in treatment-naive HIV-infected individuals.
Topics: Adolescent; Adult; Anti-HIV Agents; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; HIV Infections; Humans; Male; Middle Aged; Placebos; Plasma; Pyridones; RNA, Viral; Treatment Outcome; Triazoles; Young Adult | 2016 |
Randomized, blinded trial of vitamin D3 for treating aromatase inhibitor-associated musculoskeletal symptoms (AIMSS).
Topics: Adult; Aged; Anastrozole; Antineoplastic Agents, Hormonal; Aromatase Inhibitors; Arthralgia; Bone Density; Breast Neoplasms; Cholecalciferol; Double-Blind Method; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Letrozole; Middle Aged; Musculoskeletal Diseases; Nitriles; Triazoles; Vitamin D | 2016 |
Efficacy and safety of deferasirox, an oral iron chelator, in heavily iron-overloaded patients with beta-thalassaemia: the ESCALATOR study.
Topics: Adolescent; Adult; Benzoates; beta-Thalassemia; Child, Preschool; Deferasirox; Deferiprone; Deferoxamine; Drug-Related Side Effects and Adverse Reactions; Female; Ferritins; Humans; Iron; Iron Chelating Agents; Iron Overload; Liver; Male; Pyridones; Treatment Outcome; Triazoles; Young Adult | 2009 |
Concurrent or sequential adjuvant letrozole and radiotherapy after conservative surgery for early-stage breast cancer (CO-HO-RT): a phase 2 randomised trial.
Topics: Aged; Aged, 80 and over; Aromatase Inhibitors; Breast Neoplasms; Combined Modality Therapy; Dermatitis; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Letrozole; Middle Aged; Nitriles; Postmenopause; Radiation-Sensitizing Agents; Survival Analysis; Triazoles | 2010 |
Anidulafungin for the treatment of candidaemia/invasive candidiasis in selected critically ill patients.
Topics: Adult; Aged; Aged, 80 and over; Anidulafungin; Antifungal Agents; Candida; Candidiasis, Invasive; Critical Illness; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Female; Fluconazole; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Voriconazole for chronic pulmonary aspergillosis: a prospective multicenter trial.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillus fumigatus; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Endoscopy; Female; Humans; Male; Middle Aged; Prospective Studies; Pulmonary Aspergillosis; Pyrimidines; Radiography, Thoracic; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Voriconazole | 2012 |
43 other study(ies) available for triazoles and Drug-Related Side Effects and Adverse Reactions
| Article | Year |
|---|---|
Hepatic safety of the antifungal triazole agent posaconazole: characterization of adverse event reports in a manufacturer's safety database.
Topics: Antifungal Agents; Chemical and Drug Induced Liver Injury; Drug-Related Side Effects and Adverse Reactions; Humans; Invasive Fungal Infections; Triazoles | 2022 |
Lessons from isavuconazole therapeutic drug monitoring at a United Kingdom Reference Center.
Topics: Adolescent; Adult; Age Factors; Aged; Aged, 80 and over; Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Mycoses; Nitriles; Pyridines; Serum; Sex Factors; Triazoles; United Kingdom; Young Adult | 2020 |
Comparing the safety and efficacy of voriconazole versus posaconazole in the prevention of invasive fungal infections in high-risk patients with hematological malignancies.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemoprevention; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Neoplasms; Hospitals, University; Humans; Invasive Fungal Infections; Male; Middle Aged; Retrospective Studies; Survival Analysis; Texas; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2017 |
Overcoming the Challenges of Low Drug Solubility in the Intravenous Formulation of Solithromycin.
Topics: Administration, Intravenous; Amino Acids; Anti-Bacterial Agents; Chemistry, Pharmaceutical; Clinical Trials, Phase I as Topic; Community-Acquired Infections; Drug-Related Side Effects and Adverse Reactions; Humans; Macrolides; Solubility; Tartrates; Triazoles | 2018 |
Primary prophylaxis of invasive fungal infections with posaconazole or itraconazole in patients with acute myeloid leukaemia or high-risk myelodysplastic syndromes undergoing intensive cytotoxic chemotherapy: A real-world comparison.
Topics: Adult; Aged; Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Invasive Fungal Infections; Invasive Pulmonary Aspergillosis; Itraconazole; Leukemia, Myeloid, Acute; Male; Middle Aged; Myelodysplastic Syndromes; Pre-Exposure Prophylaxis; Retrospective Studies; Treatment Failure; Triazoles | 2018 |
S-allylmercaptocysteine attenuates posaconazole-induced adverse effects in mice through antioxidation and anti-inflammation.
Topics: Animals; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antioxidants; Colon; Cysteine; Cytokines; Diarrhea; Drug-Related Side Effects and Adverse Reactions; Garlic; Humans; Inflammation Mediators; Intestinal Mucosa; Mice; Mice, Inbred Strains; Microspheres; Triazoles | 2018 |
Tolerability of isavuconazole after posaconazole toxicity in leukaemia patients.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Chemical and Drug Induced Liver Injury; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Leukemia; Liver Function Tests; Male; Middle Aged; Mycoses; Nitriles; Pyridines; Retrospective Studies; Triazoles; Young Adult | 2019 |
Managing invasive aspergillosis in haematological patients in the era of resistance polymerase chain reaction and increasing triazole resistance: A modelling study of different strategies.
Topics: Antifungal Agents; Aspergillus; Bronchoalveolar Lavage Fluid; Computer Simulation; Diagnostic Tests, Routine; Disease Management; Drug Resistance, Fungal; Drug-Related Side Effects and Adverse Reactions; Hematologic Diseases; Humans; Invasive Pulmonary Aspergillosis; Microbial Sensitivity Tests; Molecular Diagnostic Techniques; Polymerase Chain Reaction; Treatment Outcome; Triazoles | 2019 |
Isavuconazole and voriconazole for the treatment of chronic pulmonary aspergillosis: A retrospective comparison of rates of adverse events.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Chronic Disease; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Nitriles; Pulmonary Aspergillosis; Pyridines; Retrospective Studies; Triazoles; United Kingdom; Voriconazole | 2019 |
Real-world use-Isavuconazole at a large academic medical center.
Topics: Academic Medical Centers; Adult; Aged; Aged, 80 and over; Antifungal Agents; Chemoprevention; Drug Substitution; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Mycoses; Nitriles; Pyridines; Retrospective Studies; Survival Analysis; Treatment Outcome; Triazoles; United States | 2019 |
Posaconazole salvage therapy: The Posifi study.
Topics: Administration, Oral; Adult; Aged; Aged, 80 and over; Antifungal Agents; Blood Chemical Analysis; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Mycoses; Retrospective Studies; Salvage Therapy; Spain; Tertiary Care Centers; Treatment Outcome; Triazoles; Withholding Treatment | 2019 |
Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy.
Topics: Adult; Aged; Aged, 80 and over; Antifungal Agents; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Invasive Fungal Infections; Male; Middle Aged; Nitriles; Pyridines; Retrospective Studies; ROC Curve; Serum; Triazoles | 2019 |
Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients.
Topics: Adult; Breast Neoplasms; Cohort Studies; Comorbidity; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Feasibility Studies; Female; Fertility Agents; Fertility Preservation; Gonadotropins; Humans; Infertility, Female; Letrozole; New York; Nitriles; Ovulation Induction; Prevalence; Retrospective Studies; Risk Factors; Treatment Outcome; Triazoles | 2013 |
An assessment of current clinical attitudes toward letrozole use in reproductive endocrinology practices.
Topics: Aromatase Inhibitors; Attitude of Health Personnel; Attitude to Health; Comorbidity; Drug-Related Side Effects and Adverse Reactions; Endocrinology; Female; Health Care Surveys; Health Knowledge, Attitudes, Practice; Humans; Infertility, Female; Letrozole; Nitriles; Off-Label Use; Ovulation Induction; Physicians; Practice Patterns, Physicians'; Prevalence; Reproductive Medicine; Risk Assessment; Triazoles; United States | 2013 |
Symptoms of endocrine treatment and outcome in the BIG 1-98 study.
Topics: Adult; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Drug-Related Side Effects and Adverse Reactions; Female; Follow-Up Studies; Humans; Incidence; Letrozole; Middle Aged; Neoplasm Grading; Neoplasm Metastasis; Nitriles; Proportional Hazards Models; Retrospective Studies; Risk Factors; Tamoxifen; Time Factors; Treatment Outcome; Triazoles; Tumor Burden | 2014 |
Posaconazole prophylaxis in neutropenic patients with hematological malignancies: limits in clinical practice.
Topics: Administration, Oral; Adolescent; Adult; Aged; Antifungal Agents; Chemoprevention; Child; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Neoplasms; Humans; Incidence; Male; Middle Aged; Mycoses; Plasma; Prospective Studies; Treatment Outcome; Triazoles; Withholding Treatment; Young Adult | 2014 |
Posaconazole salvage treatment for invasive fungal infection.
Topics: Adult; Aged; Antifungal Agents; Byssochlamys; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Mucor; Mycoses; Retrospective Studies; Salvage Therapy; Survival Analysis; Time Factors; Treatment Outcome; Triazoles; Withholding Treatment | 2014 |
Drug utilization, safety, and effectiveness of exenatide, sitagliptin, and vildagliptin for type 2 diabetes in the real world: data from the Italian AIFA Anti-diabetics Monitoring Registry.
Topics: Adamantane; Aged; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Drug Utilization; Drug-Related Side Effects and Adverse Reactions; Exenatide; Female; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Italy; Male; Metformin; Middle Aged; Monitoring, Physiologic; Nitriles; Peptides; Pyrazines; Pyrrolidines; Registries; Sex Factors; Sitagliptin Phosphate; Triazoles; Venoms; Vildagliptin | 2014 |
Antifungal prophylaxis with posaconazole vs. fluconazole or itraconazole in pediatric patients with neutropenia.
Topics: Adolescent; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Cohort Studies; Drug-Related Side Effects and Adverse Reactions; Female; Fluconazole; Humans; Incidence; Infant; Itraconazole; Male; Mycoses; Neoplasms; Neutropenia; Retrospective Studies; Treatment Outcome; Triazoles | 2015 |
Clinical outcome of maraviroc-containing therapy in heavily pre-treated HIV-1-infected patients.
Topics: Adolescent; Adult; Aged; Anti-HIV Agents; CD4 Lymphocyte Count; Cyclohexanes; Drug-Related Side Effects and Adverse Reactions; Female; HIV Infections; HIV-1; Humans; Male; Maraviroc; Middle Aged; Retrospective Studies; Treatment Outcome; Triazoles; Viral Load; Viral Tropism; Young Adult | 2016 |
Safety, clinical effectiveness and trough plasma concentrations of intravenous posaconazole in patients with haematological malignancies and/or undergoing allogeneic haematopoietic stem cell transplantation: off-trial experience.
Topics: Administration, Intravenous; Adult; Antifungal Agents; Australia; Chemoprevention; Drug-Related Side Effects and Adverse Reactions; Female; Hematologic Neoplasms; Hematopoietic Stem Cell Transplantation; Humans; Male; Middle Aged; Mycoses; Plasma; Retrospective Studies; Transplantation, Homologous; Treatment Outcome; Triazoles | 2016 |
A computational model predicts adjunctive pharmacotherapy for cardiac safety via selective inhibition of the late cardiac Na current.
Topics: Action Potentials; Animals; Anti-Arrhythmia Agents; Cell Survival; Computer Simulation; Drug-Related Side Effects and Adverse Reactions; Electrocardiography; Heart; Humans; Models, Biological; Myocardium; Myocytes, Cardiac; Patch-Clamp Techniques; Pyridines; Rabbits; Sodium Channels; Triazoles | 2016 |
Posaconazole plasma concentrations in pediatric patients receiving antifungal prophylaxis during neutropenia.
Topics: Adolescent; Age Factors; Antifungal Agents; Chemoprevention; Child; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Infant; Infant, Newborn; Male; Mycoses; Neutropenia; Plasma; Retrospective Studies; Sex Factors; Triazoles | 2017 |
New drugs08, part 2.
Topics: Acromegaly; Adult; Anti-Bacterial Agents; Anti-HIV Agents; Antineoplastic Agents; Biopterins; Carbapenems; Child; Child, Preschool; Cyclohexanes; Doripenem; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Epothilones; Humans; Infant; Maraviroc; Peptides, Cyclic; Pharmaceutical Preparations; Phenylketonurias; Pyrimidines; Pyrrolidinones; Raltegravir Potassium; Sirolimus; Somatostatin; Triazoles | 2008 |
Safety and efficacy of combined chelation therapy with deferasirox and deferoxamine in a gerbil model of iron overload.
Topics: Animals; Benzoates; Deferasirox; Deferoxamine; Disease Models, Animal; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Gerbillinae; Heart; Iron Overload; Liver; Organ Size; Treatment Outcome; Triazoles | 2008 |
What can we learn from drug marketing efficiency?
Topics: Adverse Drug Reaction Reporting Systems; Drug Approval; Drug Industry; Drug-Related Side Effects and Adverse Reactions; Marketing; Pyrazines; Sitagliptin Phosphate; Time Factors; Triazoles | 2008 |
Ethical issues and risk/benefit assessment of iron chelation therapy: advances with deferiprone/deferoxamine combinations and concerns about the safety, efficacy and costs of deferasirox [Kontoghiorghes GJ, Hemoglobin 2008; 32(1-2):1-15.].
Topics: Benzoates; Chelation Therapy; Deferasirox; Deferiprone; Deferoxamine; Drug Costs; Drug-Related Side Effects and Adverse Reactions; Hematologic Diseases; Humans; Iron Chelating Agents; Pyridones; Risk Assessment; Siderophores; Triazoles | 2008 |
Safe management of tacrolimus together with posaconazole in lung transplant patients with cystic fibrosis.
Topics: Adult; Antifungal Agents; Aspergillosis; Candidiasis; Cystic Fibrosis; Cytochrome P-450 CYP3A; Cytochrome P-450 CYP3A Inhibitors; Drug Interactions; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Female; Graft Rejection; Humans; Immunosuppressive Agents; Itraconazole; Lung Transplantation; Male; Microbial Sensitivity Tests; Mycoses; Prescriptions; Pyrimidines; Tacrolimus; Triazoles; Voriconazole | 2009 |
[Designing a tool to describe drug interactions and adverse events for learning and clinical routine].
Topics: Antifungal Agents; Audiovisual Aids; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Education, Pharmacy, Continuing; Immunosuppressive Agents; Leukocyte Count; Pharmacists; Pyrimidines; Software; Students, Pharmacy; Tacrolimus; Triazoles; Voriconazole | 2009 |
Drug interactions and adverse events associated with antimycotic drugs used for invasive aspergillosis in hematopoietic SCT.
Topics: Amphotericin B; Antifungal Agents; Aspergillosis; Caspofungin; Drug Interactions; Drug-Related Side Effects and Adverse Reactions; Echinocandins; Hematopoietic Stem Cell Transplantation; Humans; Lipopeptides; Prevalence; Pyrimidines; Retrospective Studies; Triazoles; Voriconazole | 2010 |
New Drugs2010, PART 1.
Topics: Acetamides; Antibodies, Monoclonal; Antimalarials; Artemether, Lumefantrine Drug Combination; Artemisinins; Azepines; Benzazepines; Benzhydryl Compounds; Benzyl Alcohol; Benzylamines; Cyclams; Cyclopropanes; Drug Combinations; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Ethanolamines; Everolimus; Febuxostat; Fluorenes; Fluoroquinolones; Gout Suppressants; Heterocyclic Compounds; Humans; Immunosuppressive Agents; Indoles; Lacosamide; Milnacipran; Oligopeptides; Phenols; Selective Serotonin Reuptake Inhibitors; Sirolimus; Tapentadol; Thiazoles; Tolvaptan; Triazoles | 2010 |
A record of 1320 suspect, deferasirox-related, patient deaths reported in 2009: insufficient toxicity testing, low efficacy and lack of transparency may endanger the lives of iron loaded patients.
Topics: Benzoates; Deferasirox; Drug-Related Side Effects and Adverse Reactions; Ethics, Medical; Ethics, Research; Humans; Iron Overload; Triazoles | 2011 |
An observational efficacy and safety analysis of the treatment of acute invasive aspergillosis using voriconazole.
Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antifungal Agents; Aspergillosis; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Male; Middle Aged; Prospective Studies; Pyrimidines; Survival Analysis; Time Factors; Treatment Outcome; Triazoles; Voriconazole; Young Adult | 2012 |
Severe hypocalcemia and drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome under deferasirox therapy for myelodysplasic syndrome.
Topics: Aged; Benzoates; Deferasirox; Drug-Related Side Effects and Adverse Reactions; Eosinophilia; Female; Humans; Hypocalcemia; Iron Chelating Agents; Myelodysplastic Syndromes; Syndrome; Triazoles | 2012 |
Successful treatment of disseminated fusariosis with voriconazole in an acute lymphoblastic leukaemia patient.
Topics: Antifungal Agents; Drug-Related Side Effects and Adverse Reactions; Female; Fusariosis; Fusarium; Humans; Immunocompromised Host; Middle Aged; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Pyrimidines; Radiography, Thoracic; Skin; Tomography, X-Ray Computed; Triazoles; Voriconazole | 2011 |
Voriconazole drug monitoring in the management of invasive fungal infection in immunocompromised children: a prospective study.
Topics: Adolescent; Antifungal Agents; Child; Child, Preschool; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Humans; Immunocompromised Host; Incidence; Infant; Male; Mycoses; Plasma; Prospective Studies; Pyrimidines; Treatment Outcome; Triazoles; Voriconazole | 2012 |
Idiosyncratic nature of voriconazole photosensitivity in children undergoing cancer therapy.
Topics: Antifungal Agents; Child, Preschool; Drug-Related Side Effects and Adverse Reactions; Humans; Male; Mycoses; Neoplasms; Photosensitivity Disorders; Pyrimidines; Triazoles; Voriconazole | 2012 |
[Quantitative evaluation method of the informational value of initial symptoms based on Bayesian theory].
Topics: Antifungal Agents; Bayes Theorem; Chemical and Drug Induced Liver Injury; Drug Information Services; Drug-Related Side Effects and Adverse Reactions; Exanthema; Humans; Pharmacists; Probability; Pyrimidines; Symptom Assessment; Triazoles; Voriconazole | 2012 |
[Withdrawal of a drug from the market for safety reasons: process and communication].
Topics: Adverse Drug Reaction Reporting Systems; Antidepressive Agents, Second-Generation; Attitude of Health Personnel; Chemical and Drug Induced Liver Injury; Communication; Drug Industry; Drug Information Services; Drug-Related Side Effects and Adverse Reactions; Humans; Interprofessional Relations; Piperazines; Switzerland; Triazoles | 2004 |
Incomplete patient drug information still a problem.
Topics: Analgesics; Canada; Drug Approval; Drug-Related Side Effects and Adverse Reactions; Humans; Information Services; Patient Education as Topic; Piperazines; Product Labeling; Safety; Triazoles | 2004 |
New drugs 06, part II.
Topics: Analgesics; Benzeneacetamides; Benzoates; Bone Density Conservation Agents; Deferasirox; Diphosphonates; Docosahexaenoic Acids; Drug Approval; Drug Combinations; Drug Interactions; Drug Monitoring; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Eicosapentaenoic Acid; gamma-Aminobutyric Acid; Humans; Ibandronic Acid; Iloprost; Indenes; Minocycline; Patient Education as Topic; Phenylacetates; Pregabalin; Tigecycline; Triazoles; Vasodilator Agents | 2006 |
Drug approvals.
Topics: Acetanilides; Alprostadil; Angina Pectoris; Benzazepines; Bone Density Conservation Agents; Diphosphonates; Drug Administration Schedule; Drug Approval; Drug Therapy; Drug-Related Side Effects and Adverse Reactions; Enzyme Inhibitors; Fatty Acids; Herpes Zoster Vaccine; Human Papillomavirus Recombinant Vaccine Quadrivalent, Types 6, 11, 16, 18; Humans; Ibandronic Acid; Insulin; Lubiprostone; Naltrexone; Narcotic Antagonists; Nurse's Role; Papillomavirus Vaccines; Patient Education as Topic; Piperazines; Quinoxalines; Ranolazine; Triazoles; United States; United States Food and Drug Administration; Varenicline | 2007 |
Design, synthesis and molecular modeling study of acylated 1,2,4-triazole-3-acetates with potential anti-inflammatory activity.
Topics: Acetates; Acylation; Animals; Anti-Inflammatory Agents; Drug Design; Drug-Related Side Effects and Adverse Reactions; Edema; Models, Molecular; Molecular Structure; Rats; Stomach Ulcer; Triazoles | 2009 |